Treatment of meningitis and septicemia in infancy with a sulphamethoxazole/trimethorpim combination
- PMID: 1090107
- DOI: 10.1111/j.1651-2227.1975.tb04376.x
Treatment of meningitis and septicemia in infancy with a sulphamethoxazole/trimethorpim combination
Abstract
Ten infants, 8 days to 10 months old, with meningitis and/or septicemia were considered therapeutic failures after conventional antibiotic treatment (i.e. kanamycin, ampicillin and sulfonamides) and given sulphamethoxazole and trimethoprim parenterally. Nine patients recovered, 8 of them rapidly, and one after prolonged treatment for 34 days when kanamycin was added to the combination. One infant improved but later died of complications not related to the treatment. High concentrations in serum and cerebrospinal fluid were achieved with a daily dose of 30-40 mg sulphamethoxazole and 6-8 mg trimethoprim per kg without signs of accumulation. No change in resistance of the bacteria isolated was seen. A hemolytic reaction, probably due to the propylene glycol in the solution, was seen in one case. Other possible side-effects in this age-group are discussed. The antibiotic combination used seems to be a good alternative in the therapy of bacterial meningitis of infants caused by gram-negative bacteria. However it should still not be given to icteric or very immature infants and probably not during the first week of life.
Similar articles
-
Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.Antimicrob Agents Chemother. 1981 Jul;20(1):81-7. doi: 10.1128/AAC.20.1.81. Antimicrob Agents Chemother. 1981. PMID: 7025751 Free PMC article.
-
Proteus morganii meningitis treated with trimethoprim-sulfamethoxazole (co-trimoxazole).Clin Pediatr (Phila). 1975 Jul;14(7):669-72. doi: 10.1177/000992287501400714. Clin Pediatr (Phila). 1975. PMID: 1040551 No abstract available.
-
Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.Chemotherapy. 1983;29(6):428-35. doi: 10.1159/000238231. Chemotherapy. 1983. PMID: 6360577
-
Trimethoprim-sulfamethoxazole for bacterial meningitis.Ann Intern Med. 1984 Jun;100(6):881-90. doi: 10.7326/0003-4819-100-6-881. Ann Intern Med. 1984. PMID: 6372565 Review.
-
Treatment of gram-negative bacillary meningitis in adults.Ann Intern Med. 1972 Aug;77(2):295-302. doi: 10.7326/0003-4819-77-2-295. Ann Intern Med. 1972. PMID: 4345082 Review. No abstract available.
Cited by
-
Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997.Emerg Infect Dis. 2003 Sep;9(9):1168-9. doi: 10.3201/eid0909.020666. Emerg Infect Dis. 2003. PMID: 14519258 Free PMC article.
-
Realities for change in child health care: existing patterns and future possibilities.Br Med J. 1980 Jun 21;280(6230):1512-5. doi: 10.1136/bmj.280.6230.1512. Br Med J. 1980. PMID: 6446349 Free PMC article.
-
Trimethoprim sulphamethoxazole in neonatal Flavobacterium meningosepticum infection.Arch Dis Child. 1984 Jun;59(6):582-4. doi: 10.1136/adc.59.6.582. Arch Dis Child. 1984. PMID: 6611137 Free PMC article.
-
Antibacterial drugs today. I.Drugs. 1975;10(1):1-55. doi: 10.2165/00003495-197510010-00001. Drugs. 1975. PMID: 1100345 Review.
-
Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.Antimicrob Agents Chemother. 1981 Jul;20(1):81-7. doi: 10.1128/AAC.20.1.81. Antimicrob Agents Chemother. 1981. PMID: 7025751 Free PMC article.